Granulocyte-macrophage colony stimulating factor in the aseptic loosening of total hip arthroplasty

被引:0
|
作者
Xu, JW
Konttinen, YT
Waris, V
GomezBarrena, E
Sorsa, T
Santavirta, S
机构
来源
JOURNAL OF ORTHOPAEDIC RHEUMATOLOGY | 1996年 / 9卷 / 03期
关键词
total hip arthroplasty; aseptic loosening; immunohistochemistry; granulocyte macrophage-colony stimulating factor;
D O I
暂无
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Aseptic loosening of total hip arthroplasty (THA) seems to be associated with and perhaps caused by a synovial-like membrane developing at the implant-bone or cement-bone interface. Granulocyte-macrophage colony stimulating factor (GM-CSF) stimulates bone resorption directly and by recruiting and activating osteoclasas. It may link the synovial-like membrane and osteolysis of the surrounding bone. Twenty samples of synovial-like membrane from the implant-bone or cement-bone interface and from the pseudocapsule were obtained from ten patients undergoing hip revision surgery due to aseptic loosening of THA. As a control group, ten samples of non-inflammatory synovial membrane were obtained from knee joints. All samples were stained immunohistochemically, Results were quantitated by a semiautomatic image analysis system. GM-CSF positive cells, mostly macrophages, were found in all periprosthetic tissues. The number of GM-CSF positive cells per mm(2) was higher in synovial-like membrane and pseudocapsule around loose THAs than in the controls (p < 0.01). The results of the present study suggest that GM-CSF is expressed and produced by periprosthetic tissue cells. It may well cause periprosthetic bone loss and aseptic loosening of THA, and deserves more detailed studies as a mediator and potential target in the prevention of loosening.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 50 条
  • [21] Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: Roles of cyclooxygenase-2
    Uemura, Yoshiki
    Kobayashi, Makoto
    Nakata, Hideshi
    Kubota, Tetsuya
    Saito, Tsuyako
    Bandobashi, Kentaro
    Taguchi, Hirokuni
    ONCOLOGY REPORTS, 2007, 17 (04) : 955 - 961
  • [22] Elevation of granulocyte-macrophage colony-stimulating factor in the placenta and blood in preeclampsia
    Hayashi, M
    Hamada, Y
    Ohkura, T
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (02) : 456 - 461
  • [23] Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis
    Wylam, ME
    Ten, R
    Prakash, UBS
    Nadrous, HF
    Clawson, ML
    Anderson, PM
    EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) : 585 - 593
  • [24] Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma
    Kaufman, Howard L.
    Ruby, Carl E.
    Hughes, Tasha
    Slingluff, Craig L., Jr.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2
  • [25] Induction of apoptosis in myeloid progenitors by granulocyte-macrophage colony-stimulating factor
    Alenzi, FQB
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2004, 61 (04) : 200 - 205
  • [26] EFFECT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN EXPERIMENTAL VISCERAL LEISHMANIASIS
    MURRAY, HW
    CERVIA, JS
    HARIPRASHAD, J
    TAYLOR, AP
    STOECKLE, MY
    HOCKMAN, H
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03): : 1183 - 1192
  • [27] Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
    Aram, Jehan
    Francis, Anna
    Tanasescu, Radu
    Constantinescu, Cris S.
    NEUROLOGY AND THERAPY, 2019, 8 (01) : 45 - 57
  • [28] Granulocyte-macrophage colony-stimulating factor-producing tumour vaccines
    Rössner, P
    Bubeník, J
    Sobota, V
    Indrová, M
    Hájková, R
    Mendoza, L
    Jandlová, T
    Símová, J
    FOLIA BIOLOGICA, 1999, 45 (05) : 173 - 177
  • [29] Granulocyte-Macrophage Colony-Stimulating Factor as a Therapeutic Target in Multiple Sclerosis
    Jehan Aram
    Anna Francis
    Radu Tanasescu
    Cris S. Constantinescu
    Neurology and Therapy, 2019, 8 : 45 - 57
  • [30] Treatment of dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor and erythropoietin
    Erduran, E
    Hacisalihoglu, S
    Ozoran, Y
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (04) : 333 - 335